Resultats de la cerca - Alison Walker

Refinar resultats
  1. 1
    A systematic review of discharge coding accuracy

    A systematic review of discharge coding accuracy per S Campbell, Marion Campbell, Jeremy Grimshaw, Alison Walker

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    A Photostable Silicon Rhodamine Platform for Optical Voltage Sensing

    A Photostable Silicon Rhodamine Platform for Optical Voltage Sensing per Yi‐Lin Huang, Alison Walker, Evan W. Miller

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Potentiation of α7 nicotinic acetylcholine receptors via an allosteric transmembrane site

    Potentiation of α7 nicotinic acetylcholine receptors via an allosteric transmembrane site per Gareth T. Young, Ruud Zwart, Alison Walker, Emanuele Sher, Neil S. Millar

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    A Distance-Dependent Distribution of Presynaptic Boutons Tunes Frequency-Dependent Dendritic Integration

    A Distance-Dependent Distribution of Presynaptic Boutons Tunes Frequency-Dependent Dendritic Integration per Federico W. Grillo, Guilherme Neves, Alison Walker, Gema Vizcay‐Barrena, Roland A. Fleck, Tiago Branco, Juan Burrone

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Parametric Functional Maps of Visual Inputs to the Tectum

    Parametric Functional Maps of Visual Inputs to the Tectum per Nikolas Nikolaou, Andrew S. Lowe, Alison Walker, Fatima Hashim Abbas, Paul R. Hunter, Ian D. Thompson, Martin P. Meyer

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Patient and public involvement in the early stages of clinical trial development: a systematic cohort investigation

    Patient and public involvement in the early stages of clinical trial development: a systematic cohort investigation per Carrol Gamble, Louise Dudley, Alison Allam, Philip Bell, Heather Goodare, Bec Hanley, Jennifer Preston, Alison Walker, Paula Williamson, Bridget Young

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    A little more conversation please? Qualitative study of researchers’ and patients’ interview accounts of training for patient and public involvement in clinical trials

    A little more conversation please? Qualitative study of researchers’ and patients’ interview accounts of training for patient and public involvement in clinical trials per Louise Dudley, Carrol Gamble, Alison Allam, Philip Bell, Deborah Buck, Heather Goodare, Bec Hanley, Jennifer Preston, Alison Walker, Paula Williamson, Bridget Young

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    An evidence base to optimise methods for involving patient and public contributors in clinical trials: a mixed-methods study

    An evidence base to optimise methods for involving patient and public contributors in clinical trials: a mixed-methods study per Carrol Gamble, Louise Dudley, Alison Allam, Philip Bell, Deborah Buck, Heather Goodare, Bec Hanley, Jennifer Preston, Alison Walker, Paula Williamson, Bridget Young

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia

    Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia per Parvathi Ranganathan, Xueyan Yu, Caroline Na, Ramasamy Santhanam, Sharon Shacham, Michael Kauffman, Alison Walker, Rebecca B. Klisovic, William Blum, Michael A. Caligiuri, Carlo M. Croce, Guido Marcucci, Ramiro Garzon

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias

    Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias per Ivana Gojo, Mariola Sadowska, Alison Walker, Eric J. Feldman, Swaminathan P. Iyer, Maria R. Baer, Edward A. Sausville, Rena G. Lapidus, Da Zhang, Yali Zhu, Ying-Ming Jou, Jennifer Poon, Karen Small, Rajat Bannerji

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia

    Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia per Parvathi Ranganathan, Xueyan Yu, Ramasamy Santhanam, Jessica Hofstetter, Alison Walker, Katherine Walsh, Bhavana Bhatnagar, Rebecca B. Klisovic, Sumithira Vasu, Mitch A. Phelps, Steven M. Devine, Sharon Shacham, Michael Kauffman, Guido Marcucci, William Blum, Ramiro Garzon

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation

    The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation per Somayeh S. Tarighat, Ramasamy Santhanam, David Frankhouser, Hanna S. Radomska, Hongchang Lai, Mirela Anghelina, H Wang, Xiaomeng Huang, Lapo Alinari, Alison Walker, Michael A. Caligiuri, Carlo M. Croce, L Li, Ramiro Garzon, C Li, Robert A. Baiocchi, Guido Marcucci

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Targeting the RAS/MAPK pathway with<i>miR-181a</i>in acute myeloid leukemia

    Targeting the RAS/MAPK pathway with<i>miR-181a</i>in acute myeloid leukemia per Xiaomeng Huang, Sebastian Schwind, Ramasamy Santhanam, Ann‐Kathrin Eisfeld, Chi‐Ling Chiang, Malori A. Lankenau, Bo Yu, Pia Hoellerbauer, Yan Jin, Somayeh S. Tarighat, Jihane Khalife, Alison Walker, Danilo Perrotti, Clara D. Bloomfield, Hongyan Wang, Robert J. Lee, Ly James Lee, Guido Marcucci

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Dose Escalation of Lenalidomide in Relapsed or Refractory Acute Leukemias

    Dose Escalation of Lenalidomide in Relapsed or Refractory Acute Leukemias per William Blum, Rebecca B. Klisovic, Heiko Becker, Xiaoxia Yang, Darlene M. Rozewski, Mitch A. Phelps, Ramiro Garzon, Alison Walker, Jason C. Chandler, Susan P. Whitman, John Curfman, Shujun Liu, Larry J. Schaaf, Jon Mickle, Cheryl Kefauver, Steven M. Devine, Michael R. Grever, and Guido Marcucci, John C. Byrd

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia

    Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia per Pearlly S. Yan, David Frankhouser, Mark W. Murphy, Hok-Hei Tam, Blanca Rodríguez, John Curfman, Michael P. Trimarchi, Susan M. Geyer, Yue-Zhong Wu, Susan P. Whitman, Klaus H. Metzeler, Alison Walker, Rebecca B. Klisovic, Samson T. Jacob, Michael R. Grever, John C. Byrd, Clara D. Bloomfield, Ramiro Garzon, William Blum, Michael A. Caligiuri, Ralf Bundschuh, Guido Marcucci

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia

    Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia per William Blum, Sebastian Schwind, Somayeh S. Tarighat, Susan M. Geyer, Ann-Kathrin Eisfeld, Susan P. Whitman, Alison Walker, Rebecca B. Klisovic, John C. Byrd, Ramasamy Santhanam, Hongyan Wang, John Curfman, Steven M. Devine, Samson T. Jacob, Celia Garr, Cheryl Kefauver, Danilo Perrotti, Kenneth K. Chan, Clara D. Bloomfield, Michael A. Caligiuri, Michael R. Grever, Ramiro Garzon, Guido Marcucci

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine

    Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine per William Blum, Ramiro Garzon, Rebecca B. Klisovic, Sebastian Schwind, Alison Walker, Susan M. Geyer, Shujun Liu, Violaine Havelange, Heiko Becker, Larry J. Schaaf, Jon Mickle, Hollie Devine, Cheryl Kefauver, Steven M. Devine, Kenneth K. Chan, Nyla A. Heerema, Clara D. Bloomfield, Michael R. Grever, John C. Byrd, Miguel A. Villalona‐Calero, Carlo M. Croce, Guido Marcucci

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia

    Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia per Christopher Hickey, Sebastian Schwind, Hanna S. Radomska, Adrienne M. Dorrance, Ramasamy Santhanam, Anjali Mishra, Yue-Zhong Wu, Houda Alachkar, Kati Maharry, Deedra Nicolet, Krzysztof Mrózek, Alison Walker, Anna M. Eiring, Susan P. Whitman, Heiko Becker, Danilo Perrotti, Lai‐Chu Wu, Xi Zhao, Todd A. Fehniger, Ravi Vij, John C. Byrd, William Blum, L. James Lee, Michael A. Caligiuri, Clara D. Bloomfield, Ramiro Garzon, Guido Marcucci

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Response to luspatercept can be predicted and improves overall survival in the real‐life treatment of LR‐MDS

    Response to luspatercept can be predicted and improves overall survival in the real‐life treatment of LR‐MDS per Angela Consagra, Luca Lanino, Najla H. Al Ali, Luis E. Aguirre, Zhuoer Xie, Onyee Chan, Gloria Andreossi, Marco Gabriele Raddi, Luca Rigodanza, Alessandro Sanna, Giorgio Mattiuz, Elena Tofacchi, Cristina Amato, Michele Tanturli, Sven De Pourcq, Alison Walker, Andrew Kuykendall, Jeffrey E. Lancet, Eric Padron, David A Sallman, Francesco Restuccia, Alessandra Perego, Marta Ubezio, Bruno Fattizzo, Marta Riva, Giulia Maggioni, Alessia Campagna, Matteo Giovanni Della Porta, Valeria Santini, Rami S. Komrokji

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial

    Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial per Maria Teresa Voso, Richard A. Larson, Dan Jones, Guido Marcucci, Thomas W. Prior, Jürgen Krauter, Michael Heuser, Serena Lavorgna, Josep Nomdedéu, Susan M. Geyer, Alison Walker, Andrew H. Wei, Jorge Sierra, Miguel Á. Sanz, Joseph Brandwein, Theo M. de Witte, Joop H. Jansen, Dietger Niederwieser, Frederick R. Appelbaum, Bruno C. Medeiros, Martin S. Tallman, Richard F. Schlenk, Arnold Ganser, Sergio Amadori, Yuan Cheng, Yin-Miao Chen, Céline Pallaud, Ling Du, Alfonso Piciocchi, Gerhard Ehninger, John C. Byrd, Christian Thiede, Konstanze Döhner, Richard M. Stone, Hartmut Döhner, Clara D. Bloomfield, Francesco Lo‐Coco

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: